Literature DB >> 18453575

Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation.

Nicolas Perez1, Subha Karumuthil-Melethil, Ruobing Li, Bellur S Prabhakar, Mark J Holterman, Chenthamarakshan Vasu.   

Abstract

Costimulatory ligands CD80 and CD86 have different binding preferences and affinities to their receptors, CD28 and CTLA-4. Earlier, we demonstrated that CD80 binds to CTLA-4 with higher affinity and has a role in suppressing T cell response. The current study demonstrates that not only did blockade of CD86 upon Ag presentation by bone marrow-derived dendritic cells (DC) to OVA-specific T cells result in induction of hyporesponsive T cells but also that these T cells could suppress the proliferative response of effector T cells. These T cells showed TGF-beta1 on their surface and secreted TGF-beta1 and IL-10 upon restimulation. Although blockade of CTLA-4 and neutralization of IL-10 profoundly inhibited the induction of these TGF-beta1(+) T cells, their ability to suppress the effector T cell proliferation was abrogated by neutralization of TGF-beta1 alone. Induction of TGF-beta1(+) and IL-10(+) T cells was found to be independent of natural CD4(+)CD25(+) regulatory T cells, demonstrating that preferential ligation of CTLA-4 by CD80 induced IL-10 production by effector T cells, which in turn promoted the secretion of TGF-beta1. Treatment of prediabetic NOD mice with islet beta cell Ag-pulsed CD86(-/-) DCs, but not CD80(-/-) DCs, resulted in the induction of TGF-beta1- and IL-10-producing cells, significant suppression of insulitis, and delay of the onset of hyperglycemia. These observations demonstrate not only that CD80 preferentially binds to CTLA-4 but also that interaction during Ag presentation can result in IL-10-dependent TGF-beta1(+) regulatory T cell induction, reinstating the potential of approaches to preferentially engage CTLA-4 through CD80 during self-Ag presentation in suppressing autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453575      PMCID: PMC2435403          DOI: 10.4049/jimmunol.180.10.6566

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Authors:  V K Kuchroo; M P Das; J A Brown; A M Ranger; S S Zamvil; R A Sobel; H L Weiner; N Nabavi; L H Glimcher
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

2.  Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.

Authors:  X Tao; S Constant; P Jorritsma; K Bottomly
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 3.  CD28/B7 system of T cell costimulation.

Authors:  D J Lenschow; T L Walunas; J A Bluestone
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

4.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

5.  Targeted engagement of CTLA-4 prevents autoimmune thyroiditis.

Authors:  Chenthamarakshan Vasu; Seema R Gorla; Bellur S Prabhakar; Mark J Holterman
Journal:  Int Immunol       Date:  2003-05       Impact factor: 4.823

6.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.

Authors:  E A Tivol; F Borriello; A N Schweitzer; W P Lynch; J A Bluestone; A H Sharpe
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

7.  TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.

Authors:  Kazuhiko Nakamura; Atsushi Kitani; Ivan Fuss; Aasta Pedersen; Naohiko Harada; Hajime Nawata; Warren Strober
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

8.  Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.

Authors:  M Croft; L M Bradley; S L Swain
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

9.  Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.

Authors:  A Nakajima; M Azuma; S Kodera; S Nuriya; A Terashi; M Abe; S Hirose; T Shirai; H Yagita; K Okumura
Journal:  Eur J Immunol       Date:  1995-11       Impact factor: 5.532

10.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Authors:  D J Lenschow; S C Ho; H Sattar; L Rhee; G Gray; N Nabavi; K C Herold; J A Bluestone
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  29 in total

1.  GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms.

Authors:  Palash Bhattacharya; Anupama Gopisetty; Balaji B Ganesh; Jian Rong Sheng; Bellur S Prabhakar
Journal:  J Leukoc Biol       Date:  2010-11-02       Impact factor: 4.962

2.  CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

Authors:  Hyun-Bae Jie; Patrick J Schuler; Steve C Lee; Raghvendra M Srivastava; Athanassios Argiris; Soldano Ferrone; Theresa L Whiteside; Robert L Ferris
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

Review 3.  Regulatory T cells in rheumatoid arthritis.

Authors:  Sujata Sarkar; David A Fox
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

4.  Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS).

Authors:  Elizabeth J Hager; Jon D Piganelli; Hubert M Tse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2011-05-24       Impact factor: 4.982

5.  Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes.

Authors:  Radhika Gudi; Nicolas Perez; Benjamin M Johnson; M Hanief Sofi; Robert Brown; Songhua Quan; Subha Karumuthil-Melethil; Chenthamarakshan Vasu
Journal:  Immunology       Date:  2019-03-07       Impact factor: 7.397

6.  Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Bellur S Prabhakar; Mark J Holterman; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

7.  Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.

Authors:  Dragana Odobasic; Virginie Oudin; Kenji Ito; Poh-Yi Gan; A Richard Kitching; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2019-08-23       Impact factor: 10.121

8.  Fungal β-glucan, a Dectin-1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response.

Authors:  Subha Karumuthil-Melethil; Radhika Gudi; Benjamin M Johnson; Nicolas Perez; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2014-08-20       Impact factor: 5.422

9.  A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice.

Authors:  Palash Bhattacharya; Jilao Fan; Christine Haddad; Abdul Essani; Anupama Gopisetty; Hatem A Elshabrawy; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2014-05-02       Impact factor: 3.969

10.  Human β defensin-3 induces chemokines from monocytes and macrophages: diminished activity in cells from HIV-infected persons.

Authors:  Velizar Petrov; Nicholas Funderburg; Aaron Weinberg; Scott Sieg
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.